University of Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany.
Lewis Katz School of Medicine at, Temple University, Philadelphia, Pennsylvania.
Respirology. 2017 Apr;22(3):575-601. doi: 10.1111/resp.13012. Epub 2017 Mar 7.
This Executive Summary of the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: (i) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; (iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; (iv)non-pharmacological therapies are comprehensively presented and (v) the importance of co-morbid conditions in managing COPD is reviewed.
本《慢性阻塞性肺疾病全球策略诊断、管理和预防执行摘要》，重点介绍了全球倡议慢性阻塞性肺疾病（GOLD）2017 年报告文件的修订和新增内容。最显著的变化包括：（i）对慢性阻塞性肺疾病的评估进行了细化，将肺量计评估与症状评估分开。现在建议仅根据患者的症状及其加重病史来确定 ABCD 组；（ii）针对 A 至 D 组中的每一组，都提出了药物治疗升级策略；（iii）在治疗评估方案中引入了治疗降级的概念；（iv）全面介绍了非药物治疗方法；（v）审查了合并症在 COPD 管理中的重要性。
